However, previous studies have shown that non-detectable levels of IL-33 and soluble ST2 levels above the median dramatically increased the 30-day mortality risk in critically ill patients (29), and that serum ST2 levels correlate with sepsis severity (30). The gene discussed is IL33; the disease is Sepsis.